Tena L. Rosser, MD

Associate Professor of Clinical Neurology and Pediatrics

Image of Tena L. Rosser, MD
Is this your profile? Click to edit

Publications

  • Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey Clin Trials. 2024 Feb; 21(1):73-84. . View in PubMed
  • Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials Clin Trials. 2024 Feb; 21(1):67-72. . View in PubMed
  • Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials Clin Trials. 2024 Feb; 21(1):6-17. . View in PubMed
  • Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder Am J Med Genet A. 2024 Jan 02. . View in PubMed
  • Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical Therapy J Pediatr Orthop. 2023 Aug 01; 43(7):e531-e537. . View in PubMed
  • A Case of Pediatric Guillain-Barré Syndrome After Respiratory Syncytial Virus Infection Pediatr Neurol. 2023 09; 146:129-131. . View in PubMed
  • Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey Am J Med Genet A. 2022 01; 188(1):71-82. . View in PubMed
  • Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1 J Atten Disord. 2021 06; 25(8):1177-1186. . View in PubMed
  • Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial Nat Med. 2021 01; 27(1):165-173. . View in PubMed
  • Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials Neurology. 2021 08 17; 97(7 Suppl 1):S15-S24. . View in PubMed
  • Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1 Neurology. 2021 08 17; 97(7 Suppl 1):S73-S80. . View in PubMed
  • Dilated cardiomyopathy in a patient with autosomal dominant EEF1A2-related neurodevelopmental disorder Eur J Med Genet. 2021 Jan; 64(1):104121. . View in PubMed
  • The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities Oncologist. 2020 07; 25(7):e1109-e1116. . View in PubMed
  • Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1 Ann Clin Transl Neurol. 2019 12; 6(12):2555-2565. . View in PubMed
  • Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma J Clin Oncol. 2019 12 10; 37(35):3446-3454. . View in PubMed
  • Reduced higher dimensional temporal dynamism in neurofibromatosis type 1 Neuroimage Clin. 2019; 22:101692. . View in PubMed
  • Case Report of Pediatric Channelopathies With UNC80 and KCNJ11 Mutations Having Abnormal Respiratory Control Treated With Positive Airway Pressure Therapy J Clin Sleep Med. 2018 08 15; 14(8):1419-1425. . View in PubMed
  • Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity Neuroimage Clin. 2017; 15:801-811. . View in PubMed
  • Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1 Neurology. 2016 Dec 13; 87(24):2575-2584. . View in PubMed
  • A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I Ann Clin Transl Neurol. 2016 04; 3(4):266-79. . View in PubMed
  • Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1 Hum Brain Mapp. 2015 Nov; 36(11):4566-81. . View in PubMed
  • Update from the 2013 International Neurofibromatosis Conference Am J Med Genet A. 2014 Dec; 164A(12):2969-78. . View in PubMed
  • Magnetic resonance spectroscopy markers of axons and astrogliosis in relation to specific features of white matter injury in preterm infants Neuroradiology. 2014 Sep; 56(9):771-9. . View in PubMed
  • Spontaneous evolution of an unusual cortical malformation in SOX2 anophthalmia syndrome Ann Indian Acad Neurol. 2013 Jul; 16(3):422-4. . View in PubMed
  • Clinical associations of occipital intermittent rhythmic delta activity J Child Neurol. 2012 Apr; 27(4):503-6. . View in PubMed
  • Alterations in white matter microstructure in neurofibromatosis-1 PLoS One. 2012; 7(10):e47854. . View in PubMed
  • Transient leukoencephalopathy associated with X-linked Charcot-Marie-Tooth disease J Child Neurol. 2010 Aug; 25(8):1013-6. . View in PubMed
  • Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma Pediatr Blood Cancer. 2008 Mar; 50(3):699-700. . View in PubMed
  • The diverse clinical manifestations of tuberous sclerosis complex: a review Semin Pediatr Neurol. 2006 Mar; 13(1):27-36. . View in PubMed
  • Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1 Neurology. 2005 Feb 08; 64(3):553-5. . View in PubMed
  • Postural headache in a child with Marfan syndrome: case report and review of the literature J Child Neurol. 2005 Feb; 20(2):153-5. . View in PubMed
  • Carotid artery pseudostenosis on MRA Pediatr Radiol. 2004 Jun; 34(6):507. . View in PubMed
  • Epstein-Barr virus-associated smooth muscle tumor of the basal ganglia in an HIV+ child: case report and review of the literature Pediatr Dev Pathol. 2004 Mar-Apr; 7(2):198-203. . View in PubMed
  • Aicardi syndrome Arch Neurol. 2003 Oct; 60(10):1471-3. . View in PubMed
  • Neurocognitive dysfunction in children with neurofibromatosis type 1 Curr Neurol Neurosci Rep. 2003 Mar; 3(2):129-36. . View in PubMed
  • Aicardi syndrome: spectrum of disease and long-term prognosis in 77 females Pediatr Neurol. 2002 Nov; 27(5):343-6. . View in PubMed